Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment

BACKGROUND: In patients with mild cognitive impairment (MCI), enhanced cerebral amyloid-β plaque burden is a high-risk factor to develop dementia with Alzheimer’s disease (AD). Not all patients have immediate access to the assessment of amyloid status (A-status) via gold standard methods. It may the...

Descripción completa

Detalles Bibliográficos
Autores principales: Doering, E., Hoenig, M. C., Bischof, G. N., Bohn, K. P., Ellingsen, L. M., van Eimeren, T., Drzezga, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605923/
https://www.ncbi.nlm.nih.gov/pubmed/35831715
http://dx.doi.org/10.1007/s00259-022-05879-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605923/
https://www.ncbi.nlm.nih.gov/pubmed/35831715
http://dx.doi.org/10.1007/s00259-022-05879-6

Ejemplares similares